Associated Papers
A cohort analysis of familial partial lipodystrophy from two Mediterranean countries.
Fernández-Pombo A et al.
Diabetes, Obesity & Metabolism, 2024
Case report: two novel PPARG pathogenic variants associated with type 3 familial partial lipodystrophy in Brazil.
da Silva MA et al.
Diabetology & Metabolic Syndrome, 2024
Familial partial lipodystrophy resulting from loss-of-function PPARγ pathogenic variants: phenotypic, clinical, and genetic features.
Soares RMV et al.
Frontiers in Endocrinology, 2024
Familial Partial Lipodystrophy-Literature Review and Report of a Novel Variant in PPARG Expanding the Spectrum of Disease-Causing Alterations in FPLD3.
Rutkowska L et al.
Diagnostics (basel, Switzerland), 2022
Genotype - phenotype correlation in an adolescent girl with pathogenic PPARy genetic variation that caused severe hypertriglyceridemia and early onset type 2 diabetes.
Gutierrez Alvarez A et al.
Annals of Pediatric Endocrinology & Metabolism, 2021
Natural helix 9 mutants of PPARγ differently affect its transcriptional activity.
Broekema MF et al.
Molecular Metabolism, 2019
Novel peroxisome proliferator-activated receptor gamma mutation in a family with familial partial lipodystrophy type 3.
Miehle K et al.
Clinical Endocrinology, 2016
Human evidence for the involvement of insulin-induced gene 1 in the regulation of plasma glucose concentration.
Krapivner S et al.
Diabetologia, 2007
Select a paper to view details